& Hybrid Lipids Hybrid LipidsI nspired by Extremophilesa nd Eukaryotes Afford Serum-StableM embranes with Low Leakage
Ta kaoki Koyanagi, [a] KevinJ.C ao, [a] Geoffray Leriche, [a] David Onofrei, [b] Gregory P. Holland, [b] Michael Mayer, [c] David Sept, [d] and Jerry Yang* [a] Abstract: This paper presents an ew hybrid lipid that fuses the ideas of molecular tethering of lipid tails used by archaea and the integration of cholesterol groups used by eukaryotes, thereby leveraging two strategies employed by nature to increase lipid packing in membranes. Liposomes comprised of pure hybrid lipids exhibited a5 -30-fold decrease in membranel eakage of smalli ons and molecules compared to liposomes that used only one strategy (lipid tetheringo rcholesterol incorporation)toincrease membrane integrity.M olecular dynamics simulations reveal that tethering of lipid tails and integrationo f cholesterol both reduce the disorderi nl ipid tails and time-dependent variance in area per lipid within am embrane, leading to tighter lipid packing. These hybrid lipid membranes have exceptional stabilityi ns erum, yet can support functional ion channels, can serve as as ubstrate for phospholipase enzymes,a nd can be used for liposomal delivery of molecules into living cells.
Reducing leakageo fi ons and small molecules across lipid membranes has been am ajor challenge for applicationsr anging from drug delivery to studies on membrane proteins. [1] [2] [3] [4] For example, in drug delivery,e ncapsulated cargo in liposomes made from commerciallya vailablel ipids typically suffer from rapid leakage, especially in the presence of serum. [3] The problem of content leakage has prompted many groups to steer away from liposomal delivery systems, and towards technologies based, for instance, onc ovalent attachment of drugst o polymericb ackbones of nanoparticles. [5] [6] [7] [8] [9] [10] However,u nlike drug-polymer conjugates that are typically limited to chemically adheringo nly one type of drug to ap olymeric backbone, the potential versatility of encapsulatingd ifferentt ypes of drugs without the need for chemical modification continues to make liposomal delivery systems an attractive argumentf or furtherd evelopmento fm embranes with low permeability. [1, [11] [12] [13] [14] In addition to drug delivery systems,ar obust and stable membrane is required when designing nanopores for sensitivea nalytical assays using lipid membranes as platforms. [15] In nature, severals trategies are employed by organismst o address problemsw ith membrane integrity.E ukaryotic organisms, for instance, typically fill defects in bilayer lipid membranesb yi ncorporating free cholesterol (chol) molecules, which leads to increased membrane stability andr educed leakiness ( Figure 1A) . [16] Archaea,o nt he other hand, generate lipids with ether linkages betweent he headgroupso rc ovalently-tethered lipid tails ( Figure 1B ), resulting in chemically stable membrane-spanning lipids that make it possible for the organismstot hrive in extreme environments. [17] We previously reported an ew class of archaea-inspired singly tethered lipids, namely,g lycerol monoalkyl glycerolt etraether with phosphocholine (PC) headgroups (GMGTPC-CH, Figure 1 . Comparison of strategies to improve membraneintegrity used by eukaryotes(A) or archaea (B) with the novel strategy that combines both strategies in the synthetic hybrid lipid introduced here (C). Figure 2 ). These lipids readily formed stable liposomes and exhibited ar eduction in small ion membrane leakage by % 2 orders of magnitudew hen compared to the leakageproperties of membranes formed from ac ommerciallya vailabled iacyl lipid, Egg PC. [18] In contrast, the addition of free cholesterol to lipid formulations has been commonly used in research laboratories to reduce membrane leakage by improving membrane integrity ( Figure 1A) . [19] Covalently attaching cholesterol to lipid tails has been shown to eliminate cholesterol leaching from liposomes. [20] [21] [22] Here, we explore the possibility to combine these two strategies used by nature for generating robust membranes by creating ah ybrid lipid that incorporates covalent cholesterol integration into atethered tetraether lipid (Figure 1C) . We compare the leakage properties of membranes comprised of this hybridl ipid to membranes formed from commercial diacyl lipids and an archaea-inspired lipid that did not comprise covalently attached cholesterol (both with and withouti ncorporation of free cholesterol in the membranes). Molecular dynamics (MD) simulations provide am olecular interpretation for the observedd ifferences in leakage properties between different lipid membrane compositions. We also examine the capability to incorporate functional ion channels into membranes from this hybrid lipid, explore if these lipids can be recognized as substrates of am embrane-active phospholipase-D (PLD) enzyme, assess the stabilityo fl iposomes comprised of these lipids in serum, and evaluate the uptake of such liposomes in cells. To the best of our knowledge,t hese studies represent the first reports of ion channel and PLD activities in pure tetraether lipid membranes, and,t herefore, provide evidencet hat these unnatural membranes retain at least some of the functional properties of natural membranes.
Scheme1summarizes the synthesis of acholesterol-integrated hybrid tetraether lipid, glycerol cholesterol-integrated glycerol tetraether lipid with phosphocholine headgroups (GcGTPC-CH, Figure2). We designed the GcGTPC-CHl ipid to comprise ac holesterol group attachedt ot he lipid headgroup via an ethylene glycol spacertoimprove flexibility and increase access for synthetic modification of the steroid. Tosylation of the 3b alcoholo nc holesterol followed by substitution of the tosyl group with ethylene glycol afforded the modified cholesterol 1 with retention of stereochemistry on cholesterol. [23] The free terminala lcohol in 1 was then converted to the corresponding tosylate, which successively reacted with 2-phenyl-1,3-dioxan-5-ol followed by as elective ring-opening of the dioxolane moiety using diisobutylaluminium hydride (DIBAL-H) to form the benzyl protected glycerolb ackbone 2.D ibromo alkane 3 [18] was then connected to the glycerolb ackbone in 2 to generate protected lipid 4 under basic conditions. Thed iol 5 was generated by deprotection of the benzyl ethers to generate the free alcohol groups. The formation of GcGTPC-CH was completed by reacting diol 5 with 2-bromoethyl dichlorophosphate, followed by displacement of the bromide by trimethylamine (see the Supporting Information and Figure S1 for details on the synthesis and characterization of 1-5).
We next probedt he physicalc haracteristics of GcGTPC-CH and examined whether replacingt he phytanyl group (which preventsn atural archaeal tetraetherl ipids from undergoing ap hase transition between 0t o8 08C) [24] in GMGTPC-CH with ac holesterol moiety would still make it possible to form stable liposomes within au seful temperature range. Differential scanning calorimetry (DSC) measurements revealed that GcGTPC-CH lipid remained in al iquid phase from 5t o6 58C( see Figure S2 in the Supporting Information). This result was in agreement with previousr eports, which showed that adding4 0-50 mol %o ff ree cholesterol to diacyl lipids [25] maintains af luid phase and diminishes its phase transition. Dynamic light scattering (DLS) measurements demonstrated that we could generate liposomes with an average hydrodynamic diameter of % 150 nm by extrusion through a1 00 nm polycarbonatem embrane (see the Supporting Information for details). Furthermore, liposomes remained structurally stable throughout the time frame of leakage experiments andw ed id not observe Using ap reviously described pH equilibrationm ethodt oe stimate initial rates of leakageo fs mall ions (e.g.,
À ,a nd other buffer ions) from liposomes, [18, 26] we first evaluated the observed initial rate of small ion membrane leakage to study whether the addition of free cholesterol (40 mol %) to 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC), GMGTPC-CH, or GcGTPC-CH liposomal formulations affectedm embrane permeationo fs malli ons (see Figure S4 in the Supporting Information). As expected, thea ddition of cholesterol to POPC resulted in at en-fold decrease in small ionm embrane leakage comparedt oc holesterol-free POPC membranes [27] ( Figure 3A ). However,t he addition of cholesterol to GMGTPC-CH did not have as ignificante ffect on the rate of small ionm embrane leakage compared with the same lipid without added free cholesterol. To furtherp robe this result,w ee xamined whether free cholesterol was capable of integrating into the membranes comprised of GMGTPC-CH. The presence of free cholesterol in the GMGTPC-CH liposomes was confirmed by measurement of both total phosphorus content and free total cholesterol using aB artlett assay [28] and an Amplex Red cholesterol assay,r espectively.T he result showedapresence of 31 AE10 mol %o f free cholesterol were indeed integrated in the GMGTPC-CH liposomes, whichisw ithin the expected range of cholesterol concentration for liposomal formulations. [29] In addition, cholesterol was also added to liposomes comprised of GcGTPC-CH lipids. However,w edidn ot detect any free cholesterol associated with the GcGTPC-CH liposomes. This absence of free cholesteroli ncorporation in GcGTPC-CH lipid membranes is in agreement with previous reports that suggest that the maximum incorporation of total cholesterol in fluid lipid membranesi s% 50 mol %f or liposomes prepared by extrusion. [29] In contrastw ith the observation that the addition of free cholesterol to GMGTPC-CH liposomes did not affect membrane leakage, liposomes comprised of pure GcGTPC-CH displayed af ivefold decrease in small ion membrane leakage compared with liposomes made with pure GMGTPC-CH ( Figure 3A ). This observed reduction in small ion membrane leakage from GcGTPC-CH is consistentw ith the hypothesis that covalently attaching cholesterol to the glycerolb ackbonei nG cGTPC-CH allows cholesterol to appropriately orient within the membrane andr esults in tighter lipid packing than GMGTPC-CH (with or without added free cholesterol).
Secondly,w ep assively encapsulatedg emcitabine (GEM, an anti-cancer drug with molecular weighto f2 63.2 gmol À1 ) [30] in liposomes to compare permeability of aneutrally charged molecule across membranes comprised of POPC/chol, GMGTPC-CH/chol or pure GcGTPC-CH. Here, we used ad ialysis assay to comparet he leakageo fG EM over a4 8h our incubation at 37 8C( see SupportingI nformation for details). In contrast to the resultsf rom the small ion leakage assay ( Figure 3A )t hat did not show as ignificant difference between POPC/chol and GMGTPC-CH/chol and af ive-fold difference between POPC/ chol or GMGTPC-CH/chol and pure GcGTPC-CH lipids, all 3lipo-somal compositions exhibited significantly different leakage profiles for encapsulatedG EM ( Figure 3B ). Remarkably, liposomes made from pure GcGTPC-CH retained6 9.1 AE 4.1 %o f GEM after 48 hours,w hereas liposomes made from POPC/chol (2.3 AE 0.1 %r etained GEM) or GMGTPC-CH/chol (7.1 AE1.2 %r etained GEM) exhibited almost complete loss of encapsulated GEM over the same periodo ft ime. These contrasting results between small ion versus small molecule leakage profiles for the differentl ipids could reflect differences in mechanism for leakage, in which small ions are believed to leak through transient membrane pores and neutralm olecules couldl eak through both membrane pores and membrane partitioning. [31] To provideamolecular interpretation for the observed trend in membrane permeabilities for POPC,G MGTPC-CH, and GcGTPC-CH, we performed molecular dynamics (MD) simulations of pure lipids in membranes( see SupportingI nformation for details). Figure 4A shows overlaid snapshots of the same individual lipids at 5nsi ntervals revealing the conformational space explored by each lipid over 50 ns. The results highlight striking differences in the order of the lipid tails between these lipids.T he reduced flexibility of lipid tails in the tetraether lipids translated to ad ecreased variance in the area occupied per lipid ( Figure 4B ), whichcouldberepresented quantitatively by the standard deviation (sd) around the mean area/lipid ( 2 ). These calculations are in good agreement with the observed experimental trends for leakage of small ions and molecules across lipid membranes (Figure 3) , supporting the concept that decreased variancei na rea per lipid leads to tighter lipid packing and lower permeability. [32] Furthermore, although our attempts at experimentally measuring permeability of water across different membrane compositions by an established light scattering [33] assay were inconclusive, MD simulations made it possible to estimate membrane water penetration for the different lipids. [34] We found 24 penetration events( i.e., transiente vents in which 3o rm ore water molecules resided anywherew ithin the hydrophobic region of am embrane over a5 0nsM Ds imulation) for pure POPC membranes, whereas we found 20 events for GMGMTPC-CH and only 1s uch event for GcGTPC-CH under the same conditions (see Figure S5 in the Supporting Information). These differences in the number of observed water penetration events presumably reflect variations in both composition and conformational freedomb etween the different lipids tails, since all lipids contained the same phosphocholine headgroups.
To explore whether the membranes comprised of hybrid GcGTPC-CH lipids retained usefulm embrane properties for potential biological applications, we examined whether 1) GcGTPC-CHl ipid membranes can act as as upport for natural ion channel forming peptides such as gramicidin A (gA), [35, 36] 2) GcGTPC-CH lipids can serve as as ubstrate for membrane active enzymes such as phospholipase-D (PLD), [37] [38] [39] 3) liposomes derived from GcGTPC are sufficiently stable in serum-containing buffers, [3, 40, 41] and 4) small molecules encapsulatedi nG cGTPC-CH liposomes can be delivered to living cells. [42] [43] [44] Gramicidin A(gA) is an antibiotic peptidethat forms well-defined ion channels in membranes. [15] Proper nanopore formation of gA in liposomal membranesa llows monovalent cations to cross between the surrounding buffer andt he intra-liposomal buffer.U sing the pH equilibrationa ssay that we used to measurep assive membrane leakage, we added gA to ab uffered solution at pH 5.8c ontaining GcGTPC-CH liposomes with encapsulated carboxyfluorescein (CF) and an intra-liposomal pH of 7.2. To determine whether gA was functional upon incorporation into the membrane, pH-dependent fluorescence emission of CF was monitored for af lux of monovalent cations (predominantly H + ion flux) into the liposome, causing an accelerated reduction of CF fluorescence when compared to liposomesw ithout the addition of gA. Similar to previously reported results with commercial lipids, [35, 36] the addition of gA to GcGTPC-CH liposomes reduced 95 %o ft he fluorescenceo fC F after 30 minutes (Figure 5A ), suggesting that the ion channels were functional within the membrane. To ensure the addition of gA did not cause the liposomes to rupture, the presence of stable liposomal structures throughout the experiment was confirmed using DLS measurements (see FigureS6i nt he Supporting Information).
Next, we assessed whether phospholipase-D (PLD), abiological membrane-active enzyme that cleaves phosphodiester bondsi nl ipids, could recognize synthetic GcGTPC-CHl ipids as as ubstrate. Although phospholipase-C( PLC) requires an ester functionality on the C-2 carbon of the glycerol backbone [45] for lipid recognition, the structural requirementsn ecessary for PLD to recognize al ipid substrate are not known. Following reported protocols for probing the activity of PLD in liposomes comprising commercial diacyllipids, [37] [38] [39] we added PLD to aliposomal suspension comprised of pure GcGTPC-CH lipids in the presenceo fC a 2 + ions at 37 8C. We observed al arge morphological change in the liposomes by DLS, beginning with liposomes with average diameter of approximately 150 nm and ending with about 1500 nm diameter objects after a30min incubation of GcGTPC-CH liposomes with PLD ( Figure 5B) . A control experiment in the same Ca 2 + -containing buffer,b ut withoutP LD, showed no change in liposomed iameter (see Figure S7 Ai nt he Supporting Information). The change in liposomal diameter after incubation with PLD wasa lso accompanied by al arge variability in size of objects measured by DLS (see Figure S7 B ). This result is consistent with previousr eports on the effects of PLD on liposomes comprised of commercial PC diacyl lipids, [37] [38] [39] which is attributed to PLD-catalyzed cleavage of the choline group from the PC headgroupa nd subsequent aggregation of liposomes upon interactions of phosphatidic acid (PA) headgroups with Ca 2 + present in solution. Using ac ommercial choline detection assay,w ea lso confirmed that PLD can indeed cleave the choline from the lipid headgroups in pure GcGTPC-CH liposomes, resulting in 76.5 AE 7.8 %r elease of choline from the lipid headgroups after 30 minutes, whereas no detectable free choline was cleavedf rom the lipids in the absence of PLD ( Figure 5B ).
To examinethe potential for GcGTPC-CH liposomes to exhibit improved stability in protein-rich environments for potential drug deliverya pplications, we used as tandard self-quenching leakage assay of CF from GMGTPC-CH (with or without added cholesterol) and GcGTPC-CH liposomes in serum-containing solutions. [46] Liposomes werei ntroduced into ab uffered solution with fetal bovines erum (30 %i nP BS) at 37 8Ca nd the increasedf luorescenceo fC Fu pon leakage from liposomes was monitored over time. We observed an initial burst of CF fluorescence when CF-encapsulated GMGTPC-CH liposomes were incubated in serum-containing solutions( Figure 5C ). CF-encapsulatedG MGTPC-CH liposomes incubated with 40 mol %f ree cholesterol, however, exhibited amore gradual CF leakage profile than GMGTPC-CH liposomes that did not contain free cholesterol. After 5days, the extento fC Fl eaked from GMGTPC-CH liposomes was similar, to the extent leaked with or without added free cholesterol. In contrast to these results from GMGTPC-CH liposomes, pure GcGTPC-CH liposomes exhibited as ignificantly reduced leakage profile of CF compared with GMGTPC-CH liposomes (with or withouta dded cholesterol), with an estimated 80 %r etention of encapsulatedC Fa fter 5days of incubation in serum ( Figure 5C ).
Lastly,a fter observing that GcGTPC-CH liposomes were relatively stable in serum-containings olutions, we examined whether GcGTPC-CH liposomes could be used to deliver small molecule cargo into living mammalian cells. After confirming that GcGTPC-CH liposomes (withoute ncapsulatedc argo) were not toxic at total lipid concentrations up to 100 mm (see Figure S8 in the Supporting Information), we examined whether pure GcGTPC-CH liposomes could deliver liposome-encapsulated calcein to KB cells (a HeLa-derived, epithelial-like cell line). We used calcein as am odel for as mall molecule drug in these studies because it is wellk nown that calceini sn ot taken up by cells as af ree molecule in cell medium, and the fluorescent properties of this molecule can be used to study its uptake in cells. In these studies, we also incorporated 0.5 mol %o f1 ,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol( DSPE-PEG)-folate into the liposomal membranes to facilitatef olate-mediated endocytosis into KB cells (see Supporting Information for details). [47] The fluorescencem icrograph in Figure5Ds hows that calcein-encapsulated GcGTPC-CH liposomesa re indeed internalized into cells, demonstratingp roofof-concept that this novel syntheticl ipid may have potential utility in liposomal drug formulations that exhibit good stability in serum-containing solutions( see Figure S9 in the Supporting Information for the results of cell uptake controle xperiments).
We have, thus, presented the design and synthesis of ah ybrid GcGTPC-CH tetraether lipid that incorporates design elements inspired from two different strategies used by nature to improve membrane robustness through modifications of membrane compositiona nd lipid structure. We demonstrated that membranes formed from pure GcGTPC-CHl ipids exhibit a5 0-fold reduction in membrane permeability to small ions when comparedw ith membranes comprised of at ypicald iacyl lipid, POPC, and af ive-fold reduction in membrane permeability compared to ap reviously reporteda rchaea-inspired tetraether lipid, GMGTPC-CH, that lacks acovalently attached cholesterolg roup. [18] We also demonstrated that pure GcGTPC-CH liposomes exhibited a % 30-foldr eduction in leakage of an eutrally charged drug, gemcitabine, compared to POPC liposomes with 40 mol %a dded cholesterol,and a % 10-fold reduction in leakage of the drug compared to GMGTPC-CH/chol liposomes. MD simulations provided somem echanistic insights that both tethering of lipid tails and incorporation of covalently attached cholesterol significantly increases the order of the lipid tails, which decreases the variancei na rea per lipid and tightens lipid packing. These MD simulations also predict that the GcGTPC-CH lipids would exhibit the lowest penetration of water molecules of all 3lipids examined,whichisinagreement with the experimentalr esultso fr educed permeability of small ion and molecules across GcGTPC-CH lipid membranes. AlthoughG cGTPC-CH lipid membranes exhibit remarkably low permeability and exceptional stability in solution( with or without serum), we also showedt hat these synthetic membranes retain properties that are typically found in natural membranes, such as the capability to incorporate functional biomolecules (here, ion channels formed from gramicidin A) and act as substrates for membrane-active enzymes (here, phospholipase-D). We also presented initial results on the cellular uptake of GcGTPC-CH liposomes containing encapsulateds mall molecule cargo (here, calcein as am odel for as mall molecule drug). Although it remains to be seen whether the apparently advantageous properties of these lipids for drug delivery applications will translatet oa ni nv ivo setting, the resultsp resented here support the concept that integrating covalently attached cholesterol groups to at ethered tetraether lipid, which combines lipid design strategies exploited by eukaryotes and archaea,l eads to membranes with significantly improved stability and reduced permeability compared membranes formed from common bilayer-forming lipid formulations.
